Cabaletta Bio Inc. (CABA): Total Asset Value of Company
Cabaletta Bio, Inc. (CABA) revenues are based on the implementation of cell therapy, specifically CART drugs for systemic lupus erythematosus; the daily price chart for the company's total assets currently stands at 240.61. Growth potential is immense due to global market reach and the high margins of patented methods. The CABA-201 IT system and strict protection of B-cell depletion technology rights provide a competitive advantage.
Comprehensive metric breakdowns and analytics for Cabaletta Bio, Inc (CABA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:CABA, cabalettabio.com
Cabaletta Bio, Inc. (CABA) aims for leadership in the autoimmune cell therapy segment through the development of CAR-T products. This indicator measures the company's total resource volume, calculated inversely via return on assets (ROA) based on equity and liabilities. Investors view this balance as the potential for funding costly clinical trials. The trend in total asset value clearly demonstrates the scale of the business expansion.
Competitors of Cabaletta Bio, Inc. (CABA)
ARGX (argenx.com) - Company Total Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|SVRA: Company Total Assets|RIGL - Cumulative Company Assets|ANAB: Company Total Assets|astriatx.com (ATXS) - Company Total Assets|Company Total Assets enGene|Aggregate Company Assets RAPT Therapeutics Inc.|Company Total Assets JBIO|Company Total Assets ACRS (Aclaris Therapeutics, Inc)|Aggregate Company Assets Kyverna Therapeutics KYTX|Aggregate Company Assets tizianalifesciences.com TLSA|VTYX (Ventyx Biosciences, Inc.) - Company Total Assets|Theratechnologies, Inc. (THTX) - Company Assets|AVTX - Cumulative Company Assets|Aggregate Business Assets Eledon Pharmaceuticals, Inc|Agenus (AGEN) - Cumulative Company Assets|Aggregate Business Assets climbbio.com|Company Total Assets ZURA|Company Total Assets aTyr Pharma Inc ATYR|Cumulative Company Assets Adagene Inc.|Aggregate Asset Value ImageneBio IMA|STTK - Company Total Assets|EQ - Aggregate Company Assets|connectbiopharm.com - Company Total Assets|IMUX (Immunic) - Company Total Asset Base|Aggregate Company Assets ATRA (Atara Biotherapeutics, Inc.)|Company Assets InflaRx GmbH (IFRX)|X4 Pharmaceuticals (XFOR) - Cumulative Company Assets|Aggregate Asset Value adicetbio.com (ACET)|Company Total Assets CELU|INmune Bio Inc - Company Total Asset Base|Barinthus Bio (BRNS) - Aggregate Company Assets|KZR - Total Business Assets|SABS (SAB Biotherapeutics) - Company Total Assets|Cumulative Company Assets akaritx.com|ENLV: Cumulative Company Assets|Company Total Asset Base Q32 Bio Corp|Company Total Assets GOVX (GeoVax Labs Inc)|Cumulative Company Assets Edesa Biotech Corp (EDSA)|Company Total Assets IBIO (iBio, Inc.)|Company Total Assets Carisma Therapeutics Inc CARM|XTLB - Company Total Assets|BOLT - Aggregate Company Assets|HCWB: Company Total Assets|APVO (Aptevo Therapeutics Inc.) - Company Total Assets|Aggregate Company Assets AIM ImmunoTech Inc. AIM|Total Asset Value of Company Aditxt Corp|GRI Bio (GRI) - Company Total Assets|Aggregate Asset Value XORTX Therapeutics Inc (XRTX)|Company Total Assets HIND (ReShape Lifesciences)|Revelation Biosciences Corp - Company Total Assets|Aggregate Company Assets Indaptus Therapeutics (INDP)|SCNI: Aggregate Asset Value|CALI (calcimedica.com) - Aggregate Company Assets|Affimed N.V. (AFMD) - Cumulative Company Assets|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA (HOOK)|IGM Biosciences, Inc. (IGMS) - Cumulative Company Assets|Aggregate Asset Value iteostherapeutics.com (ITOS)|Company Total Assets OCEA|TC BioPharm (Holdings) Plc - Company Total Asset Base|THRD: Aggregate Company Assets